Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea flag South Korea · Delayed Price · Currency is KRW
52,500
-100 (-0.19%)
Mar 26, 2025, 3:30 PM KST

Celltrion Pharm Market Cap

Celltrion Pharm has a market cap or net worth of 2.29 trillion as of March 25, 2025. Its market cap has decreased by -47.34% in one year.

Market Cap
2.29T
Enterprise Value
n/a
Revenue
274.73B
Ranking
n/a
PE Ratio
88.40
Stock Price
52,500.00

Market Cap Chart

Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 2.29T, an increase of 3,347.39%. That is a compound annual growth rate of 20.31%.

History

DateMarket Cap% Change
Mar 25, 20252,288.08B-7.23%
Dec 30, 20242,466.43B-35.41%
Dec 28, 20233,818.49B44.48%
Dec 29, 20222,642.93B-43.45%
Dec 30, 20214,673.68B-46.31%
Dec 30, 20208,705.45B511.51%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 76.73T
Celltrion 39.75T
ALTEOGEN 19.85T
Yuhan 8,954.41B
SK Biopharmaceuticals 8,160.24B
HLB Co., Ltd. 7,041.76B
Sam Chun Dang Pharm. 4,467.76B
LigaChem Biosciences 3,606.43B
Market Cap Rankings